29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
“OK Boomer” is having a moment on the internet, appearing often in viral jokes and memes. It is wi...
Read More >
The coronavirus epidemic has disrupted our world in ways we could not have imagined a few weeks ago....
Read More >
Many people in the construction industry believe the force majeure clause waives the requirement for...
Read More >
ALBUQUERQUE - The U.S. Equal Employment Opportunity Commission (EEOC) and LifeWell Living Center, LL...
Read More >
On December 23, 2020, the U.S. Senate unanimously passed the Competitive Health Insurance Reform Act...
Read More >
The dreaded Change Order or CO is almost unavoidable on most projects. COs commonly result because o...
Read More >